Anzeige
Mehr »
Donnerstag, 04.06.2026 - Börsentäglich über 12.000 News
Wolfram-Aktie im Fokus: US-Militär verbannt China-Wolfram: Profitiert Western Star Resources vom neuen Gesetz?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Zacks

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiVictoria's Secret Q1 Earnings Top Guidance on Double-Digit Sales Growth
MiStrong Performance Continues at CSTM's A&T Segment: What's Next?
MiARM Shares Surge 270% in 2026: Buy, Hold, or Wait for a Pullback?
MiHere's Why Investors Should Add ED to Their Portfolio Right Now
MiThe AI Boom is Even Bigger than We Thought
MiIs Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Mi3 Reasons Why Growth Investors Shouldn't Overlook WisdomTree, Inc. (WT)
MiTapestry (TPR) is an Incredible Growth Stock: 3 Reasons Why
MiFomento Economico (FMX) is an Incredible Growth Stock: 3 Reasons Why
MiHere is Why Growth Investors Should Buy Karooooo (KARO) Now
Mi3 Reasons Why Growth Investors Shouldn't Overlook Constellation Software (CNSWF)
MiIs Everpure (P) a Solid Growth Stock? 3 Reasons to Think "Yes"
Mi3 Reasons Growth Investors Will Love Digi International (DGII)
MiWFRD to Acquire NCS Multistage, Strengthen Well Completions Portfolio
MiVisa Down 14% in a Year, But the Disruption Thesis Weakens: Buy Now?
MiCan CuriosityStream (CURI) Run Higher on Rising Earnings Estimates?
MiPLMR Stock Declines 39.1% in a Year: What Should Investors Do Now?
MiPalo Alto Networks Q3 Earnings and Revenues Surpass Estimates
MiGitLab Shares Down Despite Q1 Earnings Beat, Revenues Up Y/Y
MiKirby (KEX) Upgraded to Buy: Here's What You Should Know
MiPrologis (PLD) Upgraded to Buy: Here's Why
MiEagle Materials (EXP) Upgraded to Buy: Here's Why
MiCan Archer Aviation's R&D Investments Support Long-Term Growth?
MiImplied Volatility Surging for Stevanato Stock Options
MiOcugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care